A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-positive Locally Advanced or Metastatic Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Docetaxel|DRUG: Paclitaxel|DRUG: Nab-paclitaxel|DRUG: Vinorelbine|DRUG: Eribulin|DRUG: Capecitabine|DRUG: Gemcitabine
Sponsor: Japan Breast Cancer Research Group
Collaborators: Chugai Pharmaceutical